Peptide Cycling: How Long to Run and When to Stop

Most peptides should not be run indefinitely. Cycling — taking a peptide for a set period, then stopping for a break — serves several important purposes:

Preventing receptor desensitization: When receptors are constantly stimulated, they can downregulate (reduce in number or sensitivity). This means the peptide becomes less effective over time. Taking breaks allows receptors to resensitize.

Maintaining natural production: Many peptides work by stimulating your body's own hormone production. Continuous stimulation can cause your body to become dependent on the external signal and reduce its own baseline production.

Safety: Longer exposure increases the risk of side effects, especially for compounds without long-term human safety data. Cycling limits cumulative exposure.

CJC-1295 + Ipamorelin, Sermorelin, GHRP-2, GHRP-6, Hexarelin:

Typical cycle: 8-12 weeks on, 4 weeks off.

Hexarelin specifically should be limited to 8 weeks maximum, as it causes more pronounced desensitization of the ghrelin receptor than other GHRPs.

MK-677 (Ibutamoren) is often run longer (12-24 weeks) because it works through a different mechanism and desensitization is slower, but insulin sensitivity should be monitored and breaks are still recommended.

Signs you need a break: diminishing sleep improvement, reduced recovery benefits, increased water retention, or numbness/tingling that does not resolve with dose reduction.

BPC-157 and TB-500:

These are typically run for the duration of the healing process rather than on a strict cycle. Common protocols:

BPC-157: 4-6 weeks on, 2 weeks off. May repeat if the injury is not fully healed.

TB-500: 4-6 week loading phase (higher dose, more frequent), then transition to maintenance dosing (lower dose, less frequent) for an additional 4-6 weeks.

The general rule: stop when the injury has healed. Unlike GH peptides, there is less concern about receptor desensitization with healing peptides, but running them indefinitely without an active injury is unnecessary.

Epithalon: Designed to be used in short courses — 10-20 days on, then off for 4-6 months. This mirrors the protocol used in the original Russian research. The effects on telomerase activation appear to persist well beyond the dosing period.

GHK-Cu (topical): Can be used continuously as part of a skincare routine. There is no strong evidence for desensitization with topical application.

GHK-Cu (injectable): 4-6 weeks on, 4 weeks off. Similar to healing peptides.

NAD+ / NMN / NR: Oral precursors can be taken continuously. IV NAD+ protocols are typically done as a series (3-5 sessions) repeated every few months.

Semax and Selank: Typically cycled 2-4 weeks on, 1-2 weeks off. Both are well-tolerated, but cycling prevents tolerance development and maintains effectiveness.

DSIP: 2-4 weeks on, 1-2 weeks off. Do not use indefinitely as the body may develop dependence for sleep initiation.

Melatonin: Can be used nightly, though periodic breaks (1 week off every 2-3 months) are recommended by some practitioners to maintain the body's own melatonin production.

Start with the minimum effective dose and duration. You can always extend a cycle, but you cannot undo overexposure.

If a peptide stops working as well as it did initially, that is your body telling you it is time for a break. Do not increase the dose — take time off instead.

Keep records. Track your doses, cycle start/stop dates, and what you notice. This makes it much easier to dial in your optimal protocol over time.

Do not stack multiple new peptides simultaneously. Introduce one at a time so you can identify what is helping and what is causing side effects.

Always consult a healthcare professional, especially for peptides that affect hormone levels (GH peptides, PT-141, Gonadorelin, Kisspeptin).